Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Snail, Inc. Sets Third Quarter 2025 Conference Call for Wednesday, November 12, 2025 at 4:30 p.m. ET
-
Form 8.3 - Empiric Student Property Plc
-
Form 8.3 - Bluefield Solar Income Fund Ltd
-
Atlanticus Reports Third Quarter 2025 Financial Results
-
Enlight Announces $1.44 Billion Debt Financing for Flagship Snowflake A Project in Arizona
-
Somnia Launches Data Streams, Bringing Real-Time Reactivity Onchain
-
Wenlay Hosts Community Fireside Chat, Discusses “Gas Sponsorship” and “Social Recovery” Features
-
Motel 6 and Studio 6 Score With New PLAY Hockey Partnership in Canada
-
The U.S. Department of War Issues New Cybersecurity Regulations — Mobilicom’s Secured Autonomy™ Framework is one of the First-to-Market Solutions Addressing these Regulations for Autonomous Syst
-
Arch Biopartners Arranges Non-Brokered Private Placement
-
Clearmind Medicine Successfully Completed First Cohort Treatment in its FDA-Approved Phase I/IIa Clinical Trial for Alcohol Use Disorder
-
Foresight Expands Global Reach Through Strategic Collaboration with Leading Chinese Stereo Solutions Manufacturer
-
Garant Expands Electric Lineup with Powerful Cordless Snow Blowers That Help Save Snowfall Slowdown
-
USX Cyber® Launches Guardient® for SMBs as CMMC Enforcement Begins - Helping Businesses Get Compliant Faster, More Affordably, and More Effectively
-
Quanted launches AI data discovery platform for buy-side front-office and data teams
-
Senseonics Holdings, Inc. to Participate in the Stifel 2025 Healthcare Conference
-
HOPE Therapeutics, Inc., an NRx Pharmaceuticals Subsidiary, Announces First-in-Florida Initiation of One Day (ONE-D) Depression Treatment in Partnership with Ampa Health
-
Rectitude Holdings Explores Strategic Collaboration with Vantage Equipment & Services Pte Ltd to Advance Green Energy Expansion
-
Celldex Announces Appointment of Teri Lawver as Chief Commercial Officer
-
Voyager Reports Third Quarter 2025 Financial and Operating Results
-
Transition Bio and Voyager Announce Collaboration to Advance Small Molecules Targeting TDP-43 in ALS and Frontotemporal Dementia
-
1st Chance Finance Announces Official Launch of New Unique Platform to Help Parents Open, Fund, and Manage Custodial IRA Accounts for Minors
-
ScanTech AI Systems Regains Nasdaq Market Value of Publicly Held Shares Compliance and Continues Progress on Strategic Re-Compliance Plan
-
Solésence, Inc. Appoints Yoana Dvorzsak as Vice President of Innovation and Product Integrity
-
Aqua Metals and Westwin Elements Sign LOI for U.S.-Produced Nickel Carbonate Supply
-
CRISPR Therapeutics Provides Business Update and Reports Third Quarter 2025 Financial Results
-
Aventis Energy Bolsters Targets Along Uranium Trends at the Corvo Uranium Project with KorrAI Technologies
-
Galectin Therapeutics Presented NAVIGATE Trial Results at the American Association for the Study of Liver Diseases (AASLD) 2025 Annual Meeting
-
Mainz Biomed to Attend the 38th Annual Meeting of the Gastroenterological Working Group of Rhineland-Palatinate (GARPS)
-
Rectitude Holdings Explores Strategic Collaboration with Vantage Equipment & Services Pte Ltd to Advance Green Energy Expansion
-
Cingulate Names Industry Veteran Bryan Downey Chief Commercial Officer to Lead Launch Preparation for CTx-1301
-
MannKind Provides Update on Phase 3 ICoN-1 Trial of Nebulized Clofazimine for NTM Lung Disease
-
SpyGlass Pharma Announces Positive 36-Month First-in-Human and 3-Month Phase I/II Trial Results for Its Novel BIM-IOL System
-
LifeMD to Participate in the BTIG Digital Health Forum
-
Jasper Therapeutics Reports Third Quarter 2025 Financial Results and Provides Corporate Update
-
Senseonics Announces Transfer to Nasdaq Stock Exchange
-
Mophie Announces New Juice Pack Battery Cases for iPhone Air, iPhone 17 Pro, and iPhone 17 Pro Max
-
BellSoft's Hardened Images Set New Standard for Container Security
-
NexQloud Ranked #2 Most Investable Project by Institutional Investors, Placing in the Top 1% of Blockchain Ventures
-
Refined Energy Corp. Provides Corporate Update and Q1 2026 Exploration Plans
-
Protara Therapeutics Announces Third Quarter 2025 Financial Results and Provides Business Update
-
Mersana Therapeutics to Host Third Quarter 2025 Conference Call on November 14, 2025
-
Madrigal Presents New Data Demonstrating Rezdiffra® (resmetirom) Significantly Improved Multiple Noninvasive Imaging Tests and Biomarkers in Patients with Compensated MASH Cirrhosis
-
Disguise and Aniplex Announce Expanded Licensing Agreement for Demon Slayer: Kimetsu no Yaiba Costumes and Accessories
-
Humacyte Announces Presentation of Positive Two-Year Results from Phase 3 Dialysis Access Trial at the American Society of Nephrology’s Kidney Week 2025
-
ArriVent BioPharma Reports Third Quarter 2025 Financial Results
-
Blaqclouds, Inc. Announces Completion of Apollo ID Integration and Opens VIP Testing to First 500 Apollo Wallet Users
-
aTyr Pharma to Present at Piper Sandler 37th Annual Healthcare Conference
-
Reviva Announces Grant of European Patent Covering Use of Brilaroxazine for the Treatment of Pulmonary Fibrosis
-
CoreCivic Announces $200 Million Increase to Share Repurchase Authorization
